The presence of targetable mutations in metastatic non-small cell lung cancer patients with malignant pleural disease is not associated with improved survival The American Thoracic Society Washington, DC

Authors

CR Gilbert
Candice L. Wilshire, Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, 1101 Madison Street, Suite 900, Seattle, WA, 98104, USA.Follow
See all authors in comments

Document Type

Presentation

Publication Date

5-21-2023

Keywords

washington; swedish; swedish cancer

Clinical Institute

Cancer

Specialty

Oncology

Comments

Gilbert CR, Meggyesy AM, Wilshire CL, Chang SC, Gorden JA

DOI

10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A2735